Translate

Tuesday, March 26, 2019

thumbnail

NBRV Nabriva Therapeutics AG gains 31% Mar 26, 2019

Developing a novel antibiotic for bacterial pneumonia.http://www.priceseries.com/trade/NBRV-Nabriva-Therapeutics-AG-stock-gains-31-percent-a-Trade-Record-by-priceSeries-2019030420190326.html

Subscribe by Email

Follow Updates Articles from This Blog via Email

No Comments

TradeVisor Product Review

Review I II III IV

Blog Archive